Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen‐deprivation therapy

Abstract

The current data suggested that men with PCa who are receiving long-term ADT are at risk for developing insulin resistance and hyperglycemia, thus leading to their increased risk of cardiovascular disease. This adverse metabolic profile developed independent of age and BMI and appeared to be a direct result of androgen deprivation.